Company iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
111.3 ^USD	-4.43%		-0.76%	+3.95%

Mar. 08	IRhythm Technologies Closes $661 Million Notes Offering	MT
Mar. 05	Irhythm Technologies Insider Sold Shares Worth $360,983, According to a Recent SEC Filing	MT

Business Summary

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Number of employees: 2,000

Sales per Business

USD in Million	2022	Weight	2023	Weight	Delta
Contracted Third-party Payors 54.2 %	224	54.5 %	267	54.2 %	+19.29%
Centers for Medicare & Medicaid 24.8 %	103	25.1 %	122	24.8 %	+18.81%
Healthcare Institutions 14.4 %	60	14.5 %	71	14.4 %	+18.79%
Non-contracted Third-party Payors 6.5 %	24	5.9 %	32	6.5 %	+32.89%

Sales per region

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	411	100.0 %	493	100.0 %	+19.90%

Managers

Managers	Title	Age	Since
Quentin Blackford CEO	Chief Executive Officer	46	21-10-03
Brice Bobzien DFI	Director of Finance/CFO	-	22-08-07
Mintu Turakhia CTO	Chief Tech/Sci/R&D Officer	-	22-04-27
Mark Day CTO	Chief Tech/Sci/R&D Officer	53	06-12-31
Stephanie Zhadkevich IRC	Investor Relations Contact	-	-
Daniel Wilson IRC	Investor Relations Contact	42	19-05-31
Sara Bender HRO	Human Resources Officer	-	20-12-31
Mazi Kiani PRN	Corporate Officer/Principal	-	19-12-31
Chad Patterson PRN	Corporate Officer/Principal	42	22-07-24
Marc Rosenbaum AUD	Comptroller/Controller/Auditor	-	23-04-30

Members of the board

Members of the board	Title	Age	Since
Abhijit Talwalkar CHM	Chairman	60	16-04-30
Mark Rubash BRD	Director/Board Member	66	16-02-29
Ralph Snyderman BRD	Director/Board Member	84	17-07-18
Bruce Bodaken BRD	Director/Board Member	72	17-07-18
Quentin Blackford CEO	Chief Executive Officer	46	21-10-03
Brian Yoor BRD	Director/Board Member	55	23-05-31
Karen Ling BRD	Director/Board Member	60	21-10-31
Cathleen Bairey-Merz BRD	Director/Board Member	68	18-04-09
Mojdeh Poul BRD	Director/Board Member	61	23-05-31

Share class

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	31,121,015	30,877,130 ( 99.22 %)	0	99.22 %

Shareholders

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.663 %	2,993,443	9.663 %	347 M $
Capital Research & Management Co. (Global Investors) 8.056 %	2,495,626	8.056 %	289 M $
BlackRock Advisors LLC 7.574 %	2,346,198	7.574 %	272 M $
Sands Capital Management LLC 7.223 %	2,237,750	7.223 %	260 M $
Artisan Partners Holdings LP 6.687 %	2,071,500	6.687 %	240 M $
AllianceBernstein LP 4.279 %	1,325,650	4.279 %	154 M $
Mackenzie Financial Corp. 4.082 %	1,264,707	4.082 %	147 M $
JPMorgan Investment Management, Inc. 3.750 %	1,161,706	3.750 %	135 M $
Holocene Advisors, LP 3.110 %	963,366	3.110 %	112 M $
Slate Path Capital LP 2.734 %	846,900	2.734 %	98 M $